Jianxin Qiu
Publications by Year
Research Areas
Osteoarthritis Treatment and Mechanisms, Bone Metabolism and Diseases, interferon and immune responses, Spine and Intervertebral Disc Pathology, Inflammasome and immune disorders
Most-Cited Works
- → Role of pyroptosis in cardiovascular diseases(2018)284 cited
- → Paroxetine Attenuates Chondrocyte Pyroptosis and Inhibits Osteoclast Formation by Inhibiting NF-κB Pathway Activation to Delay Osteoarthritis Progression(2023)46 cited
- → Induction of Regulatory B-Cells by Mesenchymal Stem Cells is Affected by SDF-1α-CXCR7(2015)37 cited
- → PD0325901, an ERK inhibitor, attenuates RANKL‐induced osteoclast formation and mitigates cartilage inflammation by inhibiting the NF-κB and MAPK pathways(2022)31 cited
- → Platelet-Derived Growth Factor-BB Inhibits Intervertebral Disc Degeneration via Suppressing Pyroptosis and Activating the MAPK Signaling Pathway(2022)24 cited
- → AZ-628 delays osteoarthritis progression via inhibiting the TNF-α-induced chondrocyte necroptosis and regulating osteoclast formation(2022)21 cited
- → Neratinib exerts dual effects on cartilage degradation and osteoclast production in Osteoarthritis by inhibiting the activation of the MAPK/NF-κB signaling pathways(2022)17 cited
- → PD184352 exerts anti-inflammatory and antioxidant effects by promoting activation of the Nrf2/HO-1 axis(2023)17 cited
- → Macrophage-derived PDGF-BB modulates glycolytic enzymes expression and pyroptosis in nucleus pulposus cells via PDGFR-β/TXNIP pathway(2024)14 cited
- → Selumetinib - a potential small molecule inhibitor for osteoarthritis treatment(2022)13 cited